tiprankstipranks
Trending News
More News >

Charmacy Pharmaceutical Approves Key Resolutions and Credit Line at AGM

Story Highlights
Charmacy Pharmaceutical Approves Key Resolutions and Credit Line at AGM

Confident Investing Starts Here:

Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) has provided an announcement.

Charmacy Pharmaceutical Co., Ltd. announced the successful passing of all resolutions during its Annual General Meeting held on May 22, 2025. Key resolutions included the approval of the 2024 financial statements, amendments to meeting procedures, and the distribution of the 2024 final dividend. The company also approved a comprehensive revolving credit line of up to RMB 2.8 billion, which is expected to enhance its financial flexibility and support future operations.

More about Charmacy Pharmaceutical Co., Ltd. Class H

Charmacy Pharmaceutical Co., Ltd. is a pharmaceutical company based in China, primarily engaged in the production and distribution of pharmaceutical products. The company focuses on providing a wide range of pharmaceutical solutions to meet market demands.

Average Trading Volume: 2,842

Technical Sentiment Signal: Sell

Current Market Cap: HK$831.6M

For a thorough assessment of 2289 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App